Previous studies have demonstrated the role of BIRC2 in promoting tumorigenesis and inhibiting apoptosis in several cancer types, including gallbladder cancer and ovarian cancer [40–44]. The gene discussed is BIRC2; the disease is ovarian carcinoma.